Drug Discovery 시장 규모, 점유율, 성장 분석 : 약제 유형별, 기술별, 프로세스별, 최종사용자별, 지역별 - 산업별 예측(2024-2031년)
Drug Discovery Market Size, Share, Growth Analysis, By Drug Type (Small Molecule Drugs, Biologic Drugs), By Technology (High Throughput Screening (HTS), Pharmacogenomics), By Process, By End User, By Region - Industry Forecast 2024-2031
상품코드:1619113
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 Drug Discovery 시장 규모는 2022년에 957억 달러로 평가되며, 2023년 1,020억 2,000만 달러에서 2031년에는 1,701억 1,000만 달러로 성장하며, 예측 기간(2024-2031년)의 CAGR은 6.6%로 성장할 전망입니다.
세계의 Drug Discovery 시장은 질병의 만연, 기술의 진보, 맞춤형 의료에 대한 수요 증가에 의해 지원되며 대폭적인 성장이 전망되고 있습니다. 혁신적인 R&D 구상은 질병 메커니즘을 규명하고 신약개발을 간소화하기 위해 유전체, 단백질체학, 계산생물학을 통합한 다학제적 접근법을 통해 새로운 신약 타깃과 효과적인 치료법에 초점을 맞추었습니다. 또한 고성능 스크리닝, 인공지능, 빅데이터 분석 등 첨단 기술을 활용하여 의약품 개발의 효율성과 성공률을 크게 향상시킬 수 있습니다. 정밀의료와 표적치료에 대한 관심이 높아짐에 따라 향후 수년간 시장이 크게 확대될 것으로 예상되며, 의료분야의 중요한 진입장벽으로 자리매김할 것으로 보입니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석과 영향
경쟁 기업 간 경쟁 관계
대체품의 위협
바이어의 교섭력
신규 진출업체의 위협
공급 기업의 교섭력
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2023년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
특허 분석
Drug Discovery 시장 규모 : 약제 유형별 & CAGR(2024-2031년)
시장 개요
저분자 의약품
생물제제
Drug Discovery 시장 규모 : 기술별 & CAGR(2024-2031년)
시장 개요
고성능 스크리닝(HTS)
약물유전체학
Combinatorial Chemistry
나노 기술
기타
Drug Discovery 시장 규모 : 프로세스별 & CAGR(2024-2031년)
시장 개요
대상 선택
리드 최적화
히트부터 리드까지의 식별
Drug Discovery 시장 규모 : 최종사용자별 & CAGR(2024-2031년)
시장 개요
제약회사
계약 연구기관(CRO)
학술연구기관
기타
Drug Discovery 시장 규모 & CAGR(2024-2031년)
북미
미국
캐나다
유럽
영국
독일
스페인
프랑스
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업의 기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2021-2023년)
주요 기업 개요
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
Johnson & Johnson
Roche Holding AG
Sanofi S.A.
GlaxoSmithKline plc
AstraZeneca plc
Bristol-Myers Squibb Company
Eli Lilly and Company
AbbVie Inc.
Amgen Inc.
Bayer AG
Takeda Pharmaceutical Company Limited
Gilead Sciences, Inc.
Biogen Inc.
Boehringer Ingelheim GmbH
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
Novo Nordisk A/S
결론과 권장사항
KSA
영문 목차
영문목차
Global Drug Discovery Market size was valued at USD 95.70 billion in 2022 and is poised to grow from USD 102.02 billion in 2023 to USD 170.11 billion by 2031, growing at a CAGR of 6.6% during the forecast period (2024-2031).
The Global Drug Discovery market is poised for substantial growth, fueled by rising disease prevalence, technological advancements, and a heightened demand for personalized medicine. Innovative R&D initiatives are focusing on novel drug targets and effective therapeutics, with an interdisciplinary approach that incorporates genomics, proteomics, and computational biology to unravel disease mechanisms and streamline drug discovery. Furthermore, the utilization of cutting-edge technologies such as high-throughput screening, artificial intelligence, and big data analytics significantly improves the efficiency and success rates of drug development. As the emphasis on precision medicine and targeted therapies intensifies, the market is set for remarkable expansion in the upcoming years, positioning it as a key player in the healthcare landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Drug Discovery Market Segmental Analysis
Global Drug Discovery Market is segmented by drug type, technology, process, end user and region. Based on drug type, the market is segmented into small molecule drugs and biologic drugs. Based on technology, the market is segmented into high throughput screening (HTS), pharmacogenomics, combinatorial chemistry, nanotechnology and other. Based on process, the market is segmented into target selection, lead optimization and hit-to-lead identification. Based on end user, the market is segmented into pharmaceutical companies, contract research organizations (CROs), academic and research institutes and other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Drug Discovery Market
A key driver of the Global Drug Discovery market is the escalating prevalence of chronic and infectious diseases. The growing rates of conditions such as cancer, cardiovascular diseases, and various infectious illnesses have intensified the demand for innovative and effective pharmaceutical solutions. This surge in disease incidence compels pharmaceutical companies and research institutions to prioritize investment in drug discovery and development efforts, accelerating the creation of new treatments and therapies to address these pressing health challenges. As a result, the landscape of drug discovery is becoming increasingly vital in the quest for improved healthcare outcomes and enhanced patient well-being worldwide.
Restraints in the Global Drug Discovery Market
The Global Drug Discovery market faces significant restraints primarily due to the high costs and the lengthy nature of the drug development process. The journey from drug discovery to market approval is intricate and resource-intensive, necessitating considerable investments in research, clinical trials, and navigating regulatory requirements. This complexity, coupled with stringent safety and efficacy standards, extends development timelines and inflates overall expenses. As a result, these factors can hinder the accessibility and affordability of innovative medications, creating challenges for stakeholders involved in the drug discovery process and potentially impacting the market's growth trajectory.
Market Trends of the Global Drug Discovery Market
In the Global Drug Discovery market, a significant trend is the escalating integration of artificial intelligence (AI) and machine learning (ML) technologies, catalyzing a transformative shift in the drug development landscape. These innovative technologies facilitate the rapid analysis of extensive biological datasets, allowing for precise identification of drug-target interactions and streamlined workflows. AI-driven virtual screening and molecular modeling not only enhance the efficiency of drug candidate identification but also reduce overall costs and timelines associated with the drug discovery process. As a result, this trend is poised to improve success rates in clinical trials and foster the emergence of novel therapeutics, ultimately reshaping the pharmaceutical industry's approach to drug development.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Driver & Opportunities
Restraints & Challenges
Porters Analysis & Impact
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Global Drug Discovery Market Size by Drug Type & CAGR (2024-2031)
Market Overview
Small Molecule Drugs
Biologic Drugs
Global Drug Discovery Market Size by Technology & CAGR (2024-2031)
Market Overview
High Throughput Screening (HTS)
Pharmacogenomics
Combinatorial Chemistry
Nanotechnology
Other
Global Drug Discovery Market Size by Process & CAGR (2024-2031)
Market Overview
Target Selection
Lead Optimization
Hit-to-Lead Identification
Global Drug Discovery Market Size by End User & CAGR (2024-2031)
Market Overview
Pharmaceutical Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
Other
Global Drug Discovery Market Size & CAGR (2024-2031)
North America (Drug Type, Technology, Process, End User)
US
Canada
Europe (Drug Type, Technology, Process, End User)
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific (Drug Type, Technology, Process, End User)
China
India
Japan
South Korea
Rest of Asia Pacific
Latin America, (Drug Type, Technology, Process, End User)
Brazil
Rest of Latin America
Middle East & Africa (Drug Type, Technology, Process, End User)
